The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure

19964,659 citationsJournal Articlebronze Open Access

Authors

Milton Packer · Columbia University

Michael R. Bristow · University of Colorado Health

Jay N. Cohn · University of Minnesota Medical Center

Wilson S. Colucci · Boston University

Michael B. Fowler · Stanford University

Edward M. Gilbert · University of Utah

Neil H. Shusterman

Abstract

Carvedilol reduces the risk or death as well as the risk of hospitalization for cardiovascular causes in patients with heart failure who are receiving treatment with digoxin, diuretics, and an angiotensin-converting-enzyme inhibitor.

Topics & Keywords

Heart Failure Treatment and Management Cardiovascular Function and Risk Factors Blood Pressure and Hypertension Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 334, Issue 21, pp. 1349-1355

DOI: 10.1056/nejm199605233342101

Field-Weighted Citation Impact: 146.01